Biomarker-Driven Treatment of Advanced Gastrointestinal Malignancies

Download these slides from our 2020 ASCO-GI live satellite symposium on biomarker-driven treatment of advanced gastrointestinal malignancies including colorectal cancer and pancreatic cancer.
Pashtoon Kasi, MD
Michael J. Pishvaian, MD, PhD
Format: Microsoft PowerPoint (.ppt)
File Size: 2.67 MB
Released: January 23, 2020

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
Array BioPharma Inc.
Bayer HealthCare Pharmaceuticals Inc.
Merck Sharp & Dohme Corp.

Related Content

Gain key clinical insights quickly with this short slideset from Clinical Care Options (CCO) on systemic therapy for advanced HCC

Mark Yarchoan, MD Released: November 30, 2020

From Clinical Care Options (CCO), watch video featuring expert perspectives on the use of immunotherapy for HCC

Lipika Goyal, MD Amit G. Singal, MD, MS Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: November 24, 2020 Expired: November 23, 2021

In slides from Clinical Care Options (CCO), experts provide insights on the optimal treatment of advanced HCC

Mark Yarchoan, MD Released: November 19, 2020

Review an expert commentary from Clinical Care Options (CCO) on choosing treatment for patients with HCC and Child-Pugh B cirrhosis

Mark Yarchoan, MD Released: November 18, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue